FY2025 · ended Dec 31, 2025 · Revenue $103.12M, +19.0% YoY · Filed Mar 24, 2026
Sanara Medtech Inc. (SMTI) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $103.1 million and a net loss of $37.6 million. Free cash flow was $2.2 million. As of Jun 30, 2026 it held $29.2 million in cash and investments and $48.5 million in total debt.
Revenue (TTM)
$109.81M
+13.0% vs year-ago TTM
Net income (TTM)
$-32.01M
-222.2% vs year-ago TTM
Operating cash flow (TTM)
$5.69M
+56.1% vs year-ago TTM
Free cash flow (TTM)
$4.50M
+5368.1% vs year-ago TTM
EPS (TTM)
$-3.68
-217.1% vs year-ago TTM
Dividend per share
None
Shares outstanding
9.17M
+3.0% vs prior year
Net cash
$-19.38M
as of Jun 30, 2026
Operating margin
7.7%
FY 2026
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- SMTI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- TX
- Headquarters
- Fort Worth, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 714256
- Former names
- WOUND MANAGEMENT TECHNOLOGIES, INC. (until Apr 3, 2019); MB SOFTWARE CORP (until Jun 10, 2008); INAV TRAVEL CORPORATION (until May 3, 1996)
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $103.1M | $86.7M | $65.0M | $45.8M | $24.1M |
| Operating income | $7.3M | $1.3M | -$4.2M | -$12.5M | -$7.4M |
| Net income | -$37.6M | -$9.7M | -$4.3M | -$7.9M | -$7.9M |
| Diluted EPS | -$4.36 | -$1.14 | -$0.52 | — | — |
| Operating cash flow | $6.8M | -$23,784 | -$3.2M | -$5.6M | -$4.8M |
| Free cash flow | $2.2M | -$229,632 | -$3.5M | -$5.7M | -$5.0M |
| Total assets | $72.9M | $88.1M | $73.9M | $61.0M | $36.4M |
| Total liabilities | $67.0M | $49.2M | $29.3M | $19.3M | $6.2M |
| Stockholders' equity | $5.9M | $39.4M | $44.8M | $41.8M | $30.6M |
| Cash and investments | $31.2M | $22.1M | $8.2M | $12.0M | $23.7M |
| Total debt | $48.2M | $32.3M | $11.8M | $819,224 | $425,443 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Other events
|
Oct 16, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Oct 1, 2026 | Sep 30, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K/A |
Amended current report
Material agreement, Regulation FD disclosure
|
Aug 11, 2026 | Jul 29, 2026 |
All 737 Sanara Medtech Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.